PRMT5-IN-48
PRMT5-IN-48 (compound D3) is an orally effective PRMT5 inhibitor (IC50=20.7 nM) with anticancer activity. PRMT5-IN-48 can inhibit the growth of various cancer cells, induce apoptosis (apoptosis), and arrest the cell cycle at the G0/G1 phase. PRMT5-IN-48 can be used for non-Hodgkin lymphoma (NHL) research[1].
Product Specifications
CAS Number
2640287-77-8
UNSPSC
12352005
Target
Histone Methyltransferase
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1C2=CC(NC3CC4(C3)CN(C4)C(C)=O)=NC=C2C5(CN1C[C@@H](CN6CCC(C=CC=C7)=C7C6)O)CC5
Molecular Formula
C30H37N5O3
Molecular Weight
515.65
References & Citations
[1]Li QQ, et al. Design, Synthesis, and Biological Evaluation of 3,4-Dihydroisoquinolin-1 (2H) -one Derivatives as Protein Arginine Methyltransferase 5 Inhibitors for the Treatment of Non-Hodgkin's Lymphoma. J Med Chem. 2025 Jan 9;68 (1) :108-134.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N2904-35D1-PE 100 µL
NMDA 2b Receptor, phosphorylated (Tyr1472) (NMDA R2b, N-methyl-D-aspartate, GRIN2B, Glutamate receptor ionotropic N-methyl D-aspartate 2B, HGNC:4586, NR2B, hNR3, N-methyl-D-aspartate receptor subunit 2B) -PE discontinued
Sign In for Pricing
View Details 
IDH3G-4412M 50 µg
Recombinant Mouse IDH3G Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details MBS6337100-01 0.1 mL
PRDM8, NT (PRDM8, PFM5, PR domain zinc finger protein 8, PR domain-containing protein 8) (MaxLight 490)
Sign In for Pricing
View Details